Exclusive

Publication

Byline

Location

US Patent Issued to SUTERRA on Sept. 29 for "Av3 mutant polypeptides for pest control" (Michigan Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,271, issued on Sept. 29, was assigned to SUTERRA LLC (Bend, Ore.). "Av3 mutant polypeptides for pest control" was invented by Lin Bao (Por... Read More


US Patent Issued to Novartis on Sept. 29 for "Compositions and methods for selective protein degradation" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,272, issued on Sept. 29, was assigned to Novartis AG (Basel, Switzerland). "Compositions and methods for selective protein degradation" wa... Read More


US Patent Issued to Sangamo Therapeutics, Takeda Pharmaceutical on Sept. 29 for "HTT repressors comprising a zinc-finger protein transcription factor" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,273, issued on Sept. 29, was assigned to Sangamo Therapeutics Inc. (Brisbane, Calif.) and Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "... Read More


US Patent Issued to KIM CELL & GENE on Sept. 29 for "Recombinant vector comprising codon-optimized TIF1Gamma polynucleotide, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,274, issued on Sept. 29, was assigned to KIM CELL & GENE Co. LTD. (Seoul, South Korea). "Recombinant vector comprising codon-optimized TIF... Read More


US Patent Issued to Nanjing Normal University on Sept. 29 for "Fusion polypeptide and polypeptide dimer, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,275, issued on Sept. 29, was assigned to Nanjing Normal University (Nanjing, China). "Fusion polypeptide and polypeptide dimer, and use th... Read More


US Patent Issued to 3H BIO. on Sept. 29 for "Peptide used for immunotherapeutics" (South Korean Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,276, issued on Sept. 29, was assigned to 3H BIO. Co. LTD. (Gyeonggi-do, South Korea). "Peptide used for immunotherapeutics" was invented b... Read More


US Patent Issued to AvenCell Europe on Sept. 29 for "Universal chimeric antigen expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders" (German Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,277, issued on Sept. 29, was assigned to AvenCell Europe GmbH (Dresden, Germany). "Universal chimeric antigen expressing immune cells for ... Read More


US Patent Issued to SMT BIO, INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY on Sept. 29 for "Chimeric antigen receptor for treatment of cancer" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,278, issued on Sept. 29, was assigned to SMT BIO Co. LTD. (Seoul, South Korea) and INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERS... Read More


US Patent Issued to AbelZeta on Sept. 29 for "Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,279, issued on Sept. 29, was assigned to AbelZeta Inc. (Rockville, Md.). "Construction of chimeric antigen receptor targeting CD20 antigen... Read More


US Patent Issued to CASE WESTERN RESERVE UNIVERSITY, THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS on Sept. 29 for "Neutrophil elastase binding peptides and compositions thereof" (Ohio Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,280, issued on Sept. 29, was assigned to CASE WESTERN RESERVE UNIVERSITY (Cleveland) and THE UNITED STATES AS REPRESENTED BY THE DEPARTMENT... Read More